Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisitionPeter B. Gilbert, Lynn Morris, Nidhi Kochar et al.|Nature Medicine|2022Cited by 132
Magnetic nanoparticles temperature measurementsIrina M. Perreard, John B. Weaver, Daniel B. Reeves et al.|Unknown|2013Cited by 7
Bayesian estimation of HIV acquisition dates for prevention trialsRaabya Rossenkhan, Paul T. Edlefsen, Elena E. Giorgi et al.|mBio|2025Cited by 3
Influence of the broadly neutralizing antibody VRC01 on HIV breakthrough virus populations in antibody-mediated prevention trialsCarolyn Williamson, James I. Mullins, Chivonne Moodley et al.|bioRxiv (Cold Spring Harbor Laboratory)|2025Cited by 1
VRC01 Selects Rare HIV Escape Mutations After Acquisition in Antibody-Mediated Prevention TrialsCarolyn Williamson, James I. Mullins, Lyle Curry et al.|bioRxiv (Cold Spring Harbor Laboratory)|2025Cited by 1